US FDA in project to assess LASIK side effects; issues warnings to 17 centres
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has teamed up on a project with the Department of Defense and the National Eye Institute to assess how many patients undergoing LASIK (laser-assisted in situ keratomileusis) go on to experience adverse effects from the vision correction procedure1.